Novel thrombin and factor Xa inhibitors: Challenges to reversal of their anticoagulation effects

Keyphrases

• Thrombin 100%
• Anticoagulation Effect 100%
• Factor Xa Inhibitors 100%
• Target-specific Oral Anticoagulants 100%
• Warfarin 42%
• Bleeding Complications 28%
• Hemostatic Agents 28%
• Pharmacology 14%
• Patient Care 14%
• Clinical Management 14%
• Randomized Clinical Trial 14%
• Evidence-based Guidelines 14%
• Coagulation Tests 14%
• Laboratory Monitoring 14%
• Bleeding Patients 14%
• Reversal Agents 14%
• Oral Anticoagulants 14%
• Over 60 Years 14%
• Bleeding Management 14%

Medicine and Dentistry

• Anticoagulation 100%
• Thrombin 100%
• Antithrombotic 100%
• Blood Clotting Factor 10a Inhibitor 100%
• Bleeding 37%
• Warfarin 37%
• Hemostat 25%
• Patient Care 12%
• Ex Vivo 12%
• Clinician 12%
• Clinical Management 12%
• Thromboembolism 12%
• Blood Clotting Test 12%
• Randomized Clinical Trials 12%
• Antidote 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Thrombin 100%
• Blood Clotting Factor 10a Inhibitor 100%
• Bleeding 37%
• Warfarin 37%
• Hemostatic Agent 25%
• Randomized Clinical Trial 12%
• Thromboembolism 12%
• Antidote 12%